NORD Stock Forecast: Nordicus Partners Corp. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 25 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Nordicus Partners Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (69): Reported profit is backed by cash, and the company is not expanding recklessly.
Value (13): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
NORD stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on NORD, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 27 Apr 2017 | BMO Capital | Downgrade | Market Perform | — |
| 10 Jan 2017 | Barclays | Downgrade | Equal-Weight | — |
| 13 June 2016 | CLSA | Downgrade | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
NORD appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
NORD vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Nordicus Partners Corp. returned −42.9% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
NORD analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- —
- Price / book
- 0.9×
- EV / EBITDA
- —
Cheaper than 74% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Return on equity
- −8.2%
- Return on assets
- −3.7%
- Dividend yield
- —
Higher than 38% of US stocks
Higher than 34% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Nordicus Partners Corp. has a market value of $58.4M and an enterprise value of $57.0M.
Revenue in the twelve months to 31 Mar 2026: $0.0.
Net income over the same four quarters: −$4.0M.
Free cash flow in the twelve months to 31 Mar 2026: −$4.3M.
Data provided by Twelve Data
NORD and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at NORD’s peer groups, ranked by the model: financial stocks · biotech stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Nordicus Partners Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about NORD
How does Ticker Nerd's model rank NORD?
As at 21 Nov 2026, Nordicus Partners Corp. ranks 25 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (69 of 100).
What is the NORD stock forecast for 2030?
No analyst covering Nordicus Partners Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NORD are extrapolating price history, which says nothing about the business.
How has NORD stock performed over the past year?
Nordicus Partners Corp. returned -42.9% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Nordicus Partners Corp. do?
Nordicus Partners Corporation is a U.S.-based business accelerator and holding company focused on helping Nordic life sciences businesses establish and operate in the American market. Its activities combine financial consulting, commercial development, operational support, and portfolio management, connecting Nordic biomedical innovation with U.S. industry expertise and market access.
About Nordicus Partners Corp.
Nordicus Partners Corporation is a U.S.-based business accelerator and holding company focused on helping Nordic life sciences businesses establish and operate in the American market. Its activities combine financial consulting, commercial development, operational support, and portfolio management, connecting Nordic biomedical innovation with U.S. industry expertise and market access. The company’s current portfolio includes Orocidin A/S and Bio-Convert A/S, preclinical biotechnology businesses developing solutions for unmet medical needs. Through these interests, Nordicus participates in the biotechnology and life sciences sectors, with exposure to research-driven products and healthcare applications. Its role extends beyond conventional consulting by supporting the identification, development, and commercialization of Nordic companies seeking a presence in the United States. Nordicus Partners Corporation therefore serves as a cross-border platform linking Scandinavian scientific enterprises with U.S. business, regulatory, and commercial resources, while maintaining a holding-company structure centered on life sciences assets and related advisory services.
CEO Mr. Henrik Rouf · United States · https://nordicuspartners.com